Prescription medication · Tetracycline Antibiotic

eravacycline

Also sold as Xerava. Xerava treats complicated infections inside your belly (intra-abdominal).

Data updated 2026-05-15

205
FDA reportsRarely reported
Rx
Availability

eravacycline (Xerava) is a prescription Tetracycline Antibiotic. Xerava treats complicated infections inside your belly (intra-abdominal).

Xerava is an antibiotic medicine. It is used to treat complicated infections in the stomach area.

View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Xerava treats complicated infections inside your belly (intra-abdominal).

Common side effects

Reactions where the IV goes into your body, Feeling sick to your stomach (nausea), Throwing up

Key warnings

Xerava can cause serious allergic reactions.

The sections below are summarized in plain English from eravacycline's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Xerava is a tetracycline antibiotic. It stops bacteria from growing. This helps your body fight off the infection.

Side Effects (from patient reports)

Based on 205 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for eravacycline, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for eravacycline each year to the FDA Adverse Event Reporting System (FAERS).

0102030405060 2019202020212022202320242025 45

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where eravacycline sits

eravacycline has more FDA adverse-event reports than 2% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is eravacycline; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 205 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2019–2025.

Total Reports

205

Reports Mentioning Death

33

16.1% of reports — not proof of cause

Hospitalization Reports

57

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 51 (35%)
Male 95 (65%)

Age Distribution

0–17 6
18–44 36
45–64 45
65–74 26
75+ 11

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
3 BLOOD FIBRINOGEN DECREASED 16
4 NAUSEA 15
5 THROMBOCYTOPENIA 14
6 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13
8 LACTIC ACIDOSIS 11
9 HYPERTRANSAMINASAEMIA 10
10 DIARRHOEA 9
11 PANCREATITIS 8
12 ACUTE RESPIRATORY DISTRESS SYNDROME 6
13 CONDITION AGGRAVATED 6
15 ENTEROCOCCAL INFECTION 6
16 PROTHROMBIN TIME PROLONGED 6
17 SEPSIS 6
18 BLOOD BILIRUBIN INCREASED 5
19 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5

Reactions in Death Reports

MULTIPLE ORGAN DYSFUNCTION SYNDROME 13
ACUTE RESPIRATORY DISTRESS SYNDROME 6
THROMBOCYTOPENIA 5
BLOOD FIBRINOGEN DECREASED 4
HYPERTRANSAMINASAEMIA 4
LACTIC ACIDOSIS 4
SHOCK 4
BLASTOMYCOSIS 3
CONDITION AGGRAVATED 3
ENTEROCOCCAL INFECTION 3

Reactions in Hospitalization Reports

BLOOD FIBRINOGEN DECREASED 9
HYPERTRANSAMINASAEMIA 8
LACTIC ACIDOSIS 8
THROMBOCYTOPENIA 8
ACUTE RESPIRATORY DISTRESS SYNDROME 6
MULTIPLE ORGAN DYSFUNCTION SYNDROME 6
BLASTOMYCOSIS 3
BLOOD BILIRUBIN INCREASED 3
ENTEROCOCCAL INFECTION 3
NAUSEA 3

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Xerava can cause serious allergic reactions. If you are allergic to tetracycline antibiotics, you should not take Xerava. Using Xerava while teeth are developing can cause tooth discoloration. It can also slow bone growth in babies and children under 8.

Common Questions

What if I'm allergic to tetracyclines?
You should not take Xerava if you are allergic to tetracycline antibiotics.
Can Xerava affect my teeth?
Yes, it can cause permanent tooth discoloration if used during tooth development (pregnancy, infancy, childhood up to 8 years).
Can Xerava affect bone growth?
Yes, it can temporarily slow bone growth if used during pregnancy or in children under 8.
What should I do if I get diarrhea while taking Xerava?
Tell your doctor right away if you get diarrhea.
Can I breastfeed while taking Xerava?
No, breastfeeding is not recommended during treatment with Xerava.
What if I am taking a blood thinner?
Your doctor may need to change the dose of your blood thinner medicine.
What if I am taking medicine that affects liver enzymes?
Your doctor may need to change the dose of Xerava.
How long will I need to take Xerava?
You will usually take Xerava for 4 to 14 days.
How is Xerava given?
Xerava is given through an IV into your vein.
What does Xerava look like?
Xerava is a yellow to orange powder before it is mixed with liquid.
What are the common side effects of eravacycline?
The registry lists Reactions where the IV goes into your body, Feeling sick to your stomach (nausea), Throwing up among the most-reported FAERS reaction terms for eravacycline. The compiled record contains 205 FDA adverse-event reports. These counts are not an individual symptom assessment.
What drug class is eravacycline?
eravacycline belongs to the Tetracycline Antibiotic drug class. It requires a prescription (Rx). Xerava treats complicated infections inside your belly (intra-abdominal).
What pregnancy or breastfeeding source fields are listed for eravacycline?
The FDA label for eravacycline contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Other drugs grouped near eravacycline - same-class peers and common alternatives.

Compare eravacycline vs amikacin side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for eravacycline: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on eravacycline

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for eravacycline

The FDA label for eravacycline (sold under brand names such as Xerava) classifies it as a prescription-only medication in the Tetracycline Antibiotic class. Xerava treats complicated infections inside your belly (intra-abdominal). Official labeling lists 3 commonly reported side effects, including Reactions where the IV goes into your body, Feeling sick to your stomach (nausea), Throwing up.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 205 voluntary reports. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: September 22, 2025

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page